BIOCHEMICAL SOCIETY TRANSACTIONS
of other values calculated by Stahl & Gordon (1983) for binding of "1-labelled /?-glucuronidase to peritoneal macrophages (lo-x 5.4litres/mol) or to human fibroblasts by Freeze et al. (1983) x I.Olitres/mol), and for binding of unlabelled enzyme to fibroblasts (lW9 x 1.6litres/mol) by Fischer et al. (1981) . Macrophages. however, had nearly twice as many surface receptors per cell as did neuronal cells.
Labelled fibroblast /?-glucuronidase thus has the capacity to bind to specific surface receptors and to be taken up rapidly by endocytosis into types of cell as diverse as macrophages and neuronal cells. This ligand can therefore be used to study the transfer of lysosomal enzymes to non-enzymedeficient recipient cells. At the plasma membrane, the /?-adrenergic receptor forms part of a ternary complex, the other two being a catalytic component (adenylate cyclase) and regulatory components (GTP-binding proteins) (Harden, 1983) . Receptor-ligand complexes formed at the cell surface are internalized and thus the fate of the catalytic and regulatory components during receptor-mediated uptake and receptor recycling requires examination.
Hepatocytes contain /?-adrenergic receptors on their surfaces (Schmelk & Hanoune, 1980) . The uptake of 12sI-cyanopindolol (a /?-adrenergic antagonist) and [3H]isoprenaline (a 8-adrenergic agonist) was investigated by analytical density-gradient centrifugation of liver homogenates at various intervals after administration of tracer amounts of isotopes via the portal vein. It was apparent that both the ligands were rapidly internalized by liver into components of low density (1. i 1-1. 14g/cm3) and high density (1.20-1 .22g/cm3) resolved on sucrose gradients and corresponding to endosomes and lysosomes. The endosome fractions were prepared from liver homogenates by a subcellular fractionation routine (Debanne et al., 1982; Evans, 1985) and approx. 12-16% of the homogenate ligand was recovered in endosome fractions D and E (Saermark et al., 1984) . The specific binding of lz5I-cyanopindolol by the endosome and plasma membrane fractions was investigated, and the number of binding sites at saturation amounts of ligand determined (Table 1) . The binding data indicated that a single receptor type was present and that a substantial number of receptors was present in the endosome fractions, even allowing for the likelihood that many binding sites were located inside the vesicles and were thus inaccessible to the ligand. Analysis (by immunoassay of cyclic AMP ; Harper & Brooker, 1975) of adenylate cyclase activities in the presence of isoprenaline and the GTP analogue guanylylimidodiphosphate and NaF indicated that the endosome fractions contained only low amounts of activity. The ratio of receptor number to enzyme activity was 14-78-fold higher in the two endosome fractions than in plasma membranes ( Table 1) .
The results thus indicated that the receptor-adenylate cyclase complex at the plasma membrane was disassembled during the endocytosis of a /?-adrenergic agonist and antagonist, with the adenylate cyclase remaining at the plasma membrane. The /?-adrenergic receptors detected in the endosome fraction add to the range of receptors identified in these fractions, e.g. asialoglycoprotein, insulin, prolactin (Evans et al., 1983) , and indicate that pools of intracellular (cytosolic) receptors exist in hepatocytes. These intracellular receptors probably function in receptor recycling and in controlling the overall number of receptors that are positioned at the cell surface for interaction with circulating ligands.
